Select Page

Pharmacy Latest Research Output: 2019

SCHOOL OF PHARMACY

  1. Egambaram OP, Pillai SK, Lategan M and Ray SS. Nanostructured ZN-Ti layered double hydroxides with reduced photocatalytic activity for sunscreen application. Journal of Nanoparticle research 2019; 21(53): 52-53
  2. Fadare JO, Ogunleye O, Iiiyasu G, Adeoti A, Schellack N, Engler D, Massele A and Godman B. Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: findings and implications. Journal of Global Antimicrobial Resistance 2019; 17: 32-136
  3. Paramadhas BDA, Tiroyakgosi C, Mpinda-Joseph P, Morokotso M, Matome M, Sinkala F, Gaolebe M, Malone B, Molosiwa E, Shanmugam MG, Raseatlholo GP, Masilo J, Oyeniran Y, Marumoloa S, Maakelo OG, Katjakae I, Kgatlwane J, Godman B and Massele A. Point prevalence study of antimicrobial use among hospitals across Botswana, findings and implications. Expert Review of Anti-Infective Therapy 2019; 17(7): 535-546
  4. Junior RLM, Godoi IP, Reis EA, Garcia MM, Guerra-Junior AA, Godman B and Ruas CM. Consumer willingness to pay for a hypothetical zika vaccine in Brazil and the implications. Expert Review of Pharmacoeconomics & Outcomes Research 2019; 19(4): 473-482
  5. Moura JCV, Moura ICG, Gaspar GR, Mendes GMS, Faria BAV, Jentzsch NS, Passos MCF, Kurdi A, Godman B and Almeida AM. The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications. Clinics 2019; 74(e950): 1-6
  6. McCabe H, Godman B, Kurdi A, Johnston K, MacBride-Stewart, Lennon J, Hurding S, Bennie M, Morton A. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Review of Respiratory Medicine 2019; 13(7): 679-689
  7. Alvarez-Madrazo S, Kavanagh K, Siebert S, Semple Y, Godman B, Almeida AM, de Assis Adurcio F, Bennie M. Discontinuation, persistance and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study. BMJ Open 2019; 9: 1-9
  8. Acosta A, Vanegas EP, Rovira J, Godman B and Bochenek T. Medicine shortages: gaps between countries and global perspectives. Frontiers in Pharmacology 2019; 10: 1-21
  9. Ali MH, Alrasheedy AA, Hassali MA, Kibuule D and Godman B. Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan. Antibiotics 2019; 8(90): 3-11
  10. Mothibe ME, Kahler-Venter CP and Osuch E. Evaluation of the in vitro effects of commercial herbal preparations significant in African traditional medicine on platelets. BMC Complementary and Alternative Medicine 2019; 19(224): 1-12
  11. Milne M, Mokoena T, Du Toit J, Dlamini Z and Schellack N. Influenza, hay fever and sinusitis: know the differences. SA Pharmaceutical Journal 2018; 85(6): 19-26
  12. Barbosa WB; De Oliveira J; Pires de Lemos LL, Gomes RM; de Oliveira HN; Ruas CM; de Assis Acurcio F; Barbui C; Bennie M; Godman B and Guerra Jr AA. Costs in the treatment of schizophrenia in adults receiving atypical antipsychotics: an-11 year cohort in Brazil. Applied Health Economics and Health Policy 218; 16: 697-709
  13. Godoi IP; Da Silva LVD; Sarker AR; Megiddo I; Morton A; Godman B; Alvarez-Madrazo S; Bennie M; Gauerra-Junior AA. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine. Expert Review of Vaccines 2018; 17(2): 1123-1133
  14. Leporowski A; Godman B; Kurdi A; MacBride-Stewart S; Ryan M; Hurding S; Do Nascimento R CRM; Bennie M and Morton A. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research 2018; 18(6): 655-666
  15. Wojkowska-Mach J; Godman B; Glassman A; Kurdi A; Pilc A; Rozanska A; Skoczynski S; Walaszek M; Bochenek T. Antibiotic consumption and antimicrobial resistance in Poland: findings and implications. Antimicrobial Resistance and Infection Control 2018; 7(136): 1-10
  16. da Silva WC; de Araujo VE; Lima EMA; dos Santos JBR; da Silva MRR; Almeid PHRF; de Assis Acurcio F; Godman B; Kurdi A; Cherchiglia ML; Andrade ELG. Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab, panitumumab) in combination with chemotherapy for metastatic colorectal: a systematic review and meta-analysis. BioDrugs 2018; 32: 585-606
  17. Kwon H-y; Kim H and Godman B. Availability and affordability of drugs with a conditional approval by the European medicines agency: comparison of Kora with other countries and the implications. Frontiers in Pharmacology 2018; 9(938): 1-9
  18. Kalungia A and Godman B. Implications of non-prescription antibiotic sales in China. The Lancet 2019; 19:1272-1273
  19. Tiroyakgosi C, Matome M; Kgatlwane J; Paramadhas BDA; Malone B; Mphinda-Joseph P; Rwegerera GM, Maika K; Mashall Y; Godman B and Massele A. Antimicrobial utilization research and activities in Botswana, the past, present and the future. Expert Review of Anti-Infective Therapy 2019; 17(10): 759-762
  20. Mpinda-Joseph; Paramadhas BEDA; Reyes G; Maruatona MB; Chise M; Monokwane-Thupiso BB; Souda S; Tiroyakgosi C and Godman B. Healthcare-associated infections icluding neonatal bloodstream infections in a leading tertiary hospital in Botswana. Hospital practice (1995) 2019; 47(4): 203-210
  21. Kalunga AC; Mwabula H; Munkombwe D; Marshall S; Schellack N; May C; St. Claire Jones A and Godman B. Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice. Journal of Chemotherapy 2019; 31(7): 378387
  22. Godman B ; Grobler C; van-de-lisle M; Wale J; Barbosa WB; Massele A; Opondo P; Petrova G; Tachkov K; Sefah I; Abdulsalim S; Alrasheedy AA; Unnikrisnan MK; Garuoliene K; Bamitale K; Kibuule D; Kalemeera F; Fadare J; Khan TA; Hussain S; Bochenek T; Chichonyi A; Mwanza J Martin AP; Hill R and Barbui C. Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opinion on Pharmacotherapy 2019; 20(18): 2237-2255
  23. Soleymani F; Godman B; Yarimanesh P Kebriaeezadeh A. Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications. Journal of Pharmaceutical Health Services Research 2019; 10: 407-413
  24. Ali MH; Alrasheedy AA; Kibuule D; Godman B; Hassali MA and Ali HMH. Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan and implications. Expert Review of Anti-Infective Therapy 2019; 17(11): 927-937
  25. Aucamp M and Milne M. The physical stability of drugs linked to quality-by-design (QbD) and in process technology (PAT) perspectives. European Journal of Pharmaceutical Sciences 2019; 139: 1-12
  26. Bassey K and Gous A. Quantification of herbal drug hypoxoside from the roots of South African hypoxis hemerocallidea using cost-effective high-performance thin-layer chromatography-densitometry. Journal of Planar Chromatology 2018; 31: 1-5
  27. Voegeli R; Gierschendorf; Summers B and Rawlings AV. Facial skin mapping: from single point-instrumental evaluation to continuous visualization of skin hydration, barrier function, skin surface Ph, and sebum in different ethnic skin typesInternational Journal of Cosmetic Science 2019; 41: 411-424.
  28. Moosa A; Bezuidenhout S; Meyer JC and Godman B. Knowledge regarding medicines management of type 2 diabetes amongst patients attending a community health centre in South Africa. Journal of Pharmaceutical Health Services Research 2019; 10: 13-21
  29. Nhira ST; Bale TA; Diale KK; Mohamed T and Bezuidenhout S. Knowledge and perceptions of pharmacists regarding the HIV rapid test in community pharmacies in Tshwane central business district, South Africa. African Journal for Physical Activity and Health Sciences (AJPHES) 2019; 25(3): 343-353
  30. Engler D and Abraham V. Dry eyes. SA Pharmaceutical Journal 2019; 6(23): 23-26
  31. Malan L; Lundie M and Engler D. Oral opioid metabolism and pharmacogenetics. SA Pharmaceutical Journal 2019; 86(2): 41-48
  32. Engler D; Makola F and Magogwa NM. Atopic dermatitis. South African Family Practice 2018; 60(6): 17-23
  33. Van der Sandt N; Schellack N; Mabope LA; Mawela MPB; Kruger D and Godman B. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two health care settings. Pediatric Infectious Disease Journal 2019; 38(2): 122-126
  34. Bodibe TC, Masemola NM and Meyer JC. Diabetic foot care. SA Pharmaceutical Journal 2019; 86(6): 17-24
  35. Godman B; Kurdi A; McCabe H; Johnson C; Barbui C; MacBride-Stewart S; Hurding S; Leporowski A; Bennie M and Morton A. Ongoing initiatives within the Scottish national health service to affect the prescribing of selective serotonin reuptake inhibitors and their influence Journal of Comparative Effectiveness Research2019; 8(7): 535547
  36. Haque M; McKimm J; Godman B; Bakar MA and Sartellie M. Initiative to reduce postoperative surgical site infections of the head and neck cancer surgery with a special emphasis on developing countries. Expert Review of Anti-Infective Therapy 2019; 19(1): 81-92
  37. Komati M; Godman B and Kibuule D. Prevalence of self-medication for acute respiratory infections in young children in Namibia: findings and implications. Journal of Research Practice 2019; 8: 220-224
  38. Krulichova IS; Selke GW; Eichler U; Lappe V; Godman B and Schubert I. Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications. Current Medical Research and Opinion 2019; 35(4): 697-704
  39. Mahmood S; Hussain S; ur Rehman T; Barbui C; Kurdi A and Godman B. Trends in the prescribing of antipsychotic in Pakistan: implications for the future. Current Medical Research and Opinion 2019; 35(1): 51-61
  40. Niaz Q; Godman B; Massele A; Campbell S; Kurdi H andKibuule D. Validity of world health organisation prescribing indicators in Namibia’s primary healthcare: finding and implications. International Journal for Quality in Health Care 2019; 31(5): 338-345
  41. Ogunleye OO; Fadare JO; Eriksen J; Oaiya O; Massele A; Truter I; Taylor SJ; Godman B and Gustafsson LL. Reported needs of information resources, research tools, connectivity and infrastructure among African pharmacological scientists to improve future patient care and health. Expert Review of Clinical Pharmacology 2019; 12(5): 481-489
  42. Opanga L; Mulaku MN; Opanga SA; Godman B and Kurdie A. Adverse effets of chemotherapy and their management in pediatric patients with non-hodgkin’s lymphoma in Kenya: a descriptive, situation analysis study. Expert Review of Anticancer Therapy 2019; 199(5): 423-430
  43. Sheikh AM; Rwegerera GM; Godman B and Habte D. Adjustments of medication dosage in patients with renal impairment in Botswana; findings and implications to improve patient care. HOSPital practice (1995) 2019; 47(5): 231-240
  44. Bananno PV; Bucsics A; Simoens S; Martin AP; Oortwijn W; Gulbinovic J; Rothe C; Timoney A; Ferrario A; Gad M; Salem A; Hoxha I; Sauermann R; Kamusheva M; Dimitrova M; Petrova G; Laius O; Selke G; Kourafalos V; Yfantopoulos J; Magnusson E; Joppi R; Jakupi A; Bochenek T; Wladysiuk M; Furtado C; Markovic-Pekovic V; Mardare I; Meshkov D; Furst J; Tomek D; Cortadellas MO; Zara C; Haycox A, Campbell S and Godman B.Proposal for a regulation on health technology assessment in Europe-opinions of policy makers, payers and academics from the field of HTA. Expert Review of Pharmacoeconomics & Outcomes Research 2019; 19(3): 251-261
  45. Rwegerera GM; Masaka A; Pina-Rivera Y; Moshomo T; Gaenamong M; Godman B; Oyewo TA; Massele A and Habte D. Determinants of glycemic control among diabetes mellitus patients in a tertiary clinic in Gaborone, Botswana: findings and implications. Hospital practice (1995) 2019; 47(1): 34-41
  46. Robertson J; Ilwamoto K; Hoxha I; Ghazaryan L; Abilova V; Cvijanovic A; Pyshnik H; Darakhvelidze M; Makalkina L; Jakupi A; Dzhakubekova A; Carp A; Cizmovic L; Rachina S; Radonijic V; Uusufi S; Aksoy M; Ibragimova M; Godman B; Kluge H and Pedersen HB. Antimicrobial medicines consumption in Eastern Europe and Central Asia-an updated cross-national study and assessment of quantitative metrics for policy action. Frontiers in Pharmacology 2019; 19: 1-13
  47. Makhele L, Matlala M, Sibanda M, Martin AP and Godman G. A cost analysis of haemodialysis and peritoneal dialysis for the management of end-stage renal failure at an academic hospital in Pretoria, South Africa. PharmacoEconomic 2019; 3: 631-641
  48. Mashaba TP, Matlala M, Godman B and Meyer J. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals. Expert Review of Clinical Pharmacology 209; 12(2): 159-168